Rats primed by infection with the intestinal nematode Nippostrongylus brasiliensis and challenged intravenously with soluble whole-worm antigen undergo systemic anaphylactic shock. The primary lesions are in the gut and include increased permeability of the mucosa together with release, into enteric secretions, of a mucosal mast cell (MMC)-specific serine proteinase, rat mast cell protease II (RMCP-ll). This enzyme is also released into the blood of shocked rats.
like enzyme (RMCP-I) in connective tissue mast cells (13) , its release into the blood circulation or gut lumen provides a unique and highly specific marker of in vivo activation of MMC. We have, therefore, measured the concentration of this enzyme within the tissues, in the intestinal secretions, and in blood in order to analyze the anti-anaphylactic activity of corticosteroids and to measure their effect on the mucosal mast cell subpopulation in rats subjected to anaphylactic shock.
MATERIALS AND METHODS Animals. Male and female outbred Wistar rats matched for age (30-36 weeks) and weight (350-450 g) were used. They were watered and fed ad lib, but food was withdrawn 24 hr before challenge.
Parasitological Techniques. The methods used to culture the nematode parasite Nippostrongylus brasiliensis and to infect rats have been described (14) . Adult whole-worm antigen was prepared as described (15) .
Treatment of Experimental Animals. Rats were allocated to groups and were treated with saline or methylprednisolone acetate (25 mg per kg of body weight) by intramuscular injection 24 and 48 hr before they were challenged intravenously with Evan's blue (2.5 mg per 100 g of body weight). The latter was dissolved either in saline alone or in saline containing 500 worm equivalents (w.e.) (15) of worm antigen. Treatment schedules are summarized in Table 1 .
Quantification of Evan's Blue and RMCP-ll. One hour after intravenous challenge, rats were exsanguinated under ether anesthesia, and their intestines were excised. Each intestine was perfused with saline and the concentration of Evan's blue in the perfusate was determined spectrophotometrically (11) . The following tissues were collected: jejunum (25 cm distal to the pylorus); ileum (10 cm proximal to the ileo caecal valve); mesenteric lymph node (MLN) (divided into two portions, one for histology); and the right lobe of the lung. Each specimen was weighed and homogenized in 3 vol of 0.15 M KCl (16) . The concentrations of RMCP-II in the tissue homogenates, gut perfusates, and serum were measured by radial immunodiffusion (11) .
Histology and Cell Counts. (i) Carnoy fixation. The following tissues were placed in Carnoy's fluid; jejunum and ileum (specimens adjacent to those used for protease determination), MLN, and the left lobe of the lung. The tissues were processed and stained with Alcian blue/Safranin as described (16).
(it) Paraformaldehyde (4%) in phosphate-buffered saline.
Portions of jejunum and ileum and ear pinnae (from naive rats) were fixed for 6 hr, transferred to 70% ethanol, and stored at 40C overnight. The tissues were dehydrated and processed into wax, and sections were stained for nonspecific esterase with the substrate napthol AS-D chloroacetate ( Fig. 1) (17) . Adjacent sections were stained with Alcian blue to show mast cells (16) .
Mast cells in both jejunum and ileum were counted per villus crypt unit (VCU) as described (16) . Mast cells were Abbreviations: MMC, mucosal mast cell; CTMC, connective tissue mast cell; RMCP, rat mast cell protease; w.e., worm equivalent; MLN, mesenteric lymph node; VCU, villus crypt unit; PCA, passive cutaneous anaphylaxis.
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Sections of ear pinnae were examined microscopically and the total number of mast cells was enumerated. The area of tissue in which mast cells were counted, excluding cartilage, was measured by projecting the sections onto equiweight paper using a photoenlarger and then calculating the area by weight analysis of the tissue outline.
Passive Cutaneous Anaphylaxis (PCA). Rats were bled via the tail vein before saline or drug treatment and again immediately before challenge with worm antigen. Sera were harvested and double dilutions were injected intradermally into the shaved backs of recipient rats, which were challenged intravenously 48 hr later with worm antigen (1000 w.e.) and Evan's blue (18) . PCA titers were expressed as the reciprocal of the highest dilution that induced blueing to a diameter of >5 mm on the underside of the skin.
The Effect of Corticosteroid Treatment of PCA. Recipient rats were injected intradermally with double dilutions of a serum sample taken from an animal immunized by two previous infections with N. brasiliensis. The recipients were immediately injected intramuscularly with either saline or methylprednisolone (25 mg per kg of body weight). These treatments were repeated 24 hr later, and PCA titers were determined after a further 24 hr.
RMCP-ll Release as a Consequence of Corticosteroid Treatment. Fifteen naive rats, allocated to three groups, were bled via the tail vein before receiving intramuscular injections of saline, methylprednisolone acetate (25 mg per kg of body weight), or betamethasone (2 mg per kg of body weight) and were bled, 1, 4, and 24 hr later; rats given betamethasone were exsanguinated at 24 hr, and the remainder were given a second dose of saline or methylprednisolone. Blood samples were taken 1 and 4 hr later, and the remaining rats were exsanguinated 24 hr after the second injection. Samples of jejunum were collected for measurement for RMCP-II concentrations and of the numbers of MMC. Sera were analyzed for RMCP-II using an ELISA technique as described (10) .
Statistical Treatment of Results. Data were analyzed using a Tektronix microcomputer using either a Student's twotailed t test or, where necessary, a Mann-Whitney U test. Simple regression analysis was performed using the same computer facilities.
RESULTS
Intestinal Permeability and Secretion of RCMP-ll. A highly significant (P < 0.001, Student's t test) 4-fold increase in the concentration of Evan's blue occurred in the intestinal lumen of sensitized animals (group I) challenged intravenously with worm antigen (Table 1 ). This response was totally suppressed in sensitized-rats that had been previously treated with methylprednisolone (group II in Table 1) .
Similarly, RMCP-II was released into the blood and into the intestinal lumen of rats in group I, but this response was again totally suppressed (P < 0.001, Mann-Whitney U test) in rats previously treated with methylprednisolone (group II, in Table 1 ). Saline injection of either untreated or drugtreated sensitized rats and antigen injection into either untreated or drug-treated naive rats induced no significant alteration of mucosal permeability or release of RMCP-II (Table 1) .
Tissue Distribution of RMCP-II. (i) Jejunum: pretreatment of rats with methylprednisolone acetate significantly (P < 0.001) depleted the jejunum of RMCP-II in both immune and naive animals ( Table 2 ). Antigen challenge of sensitized rats was without effect when mucosal concentrations of RMCP-II were compared with those in immune rats challenged with saline (Table 2 ). (ii) Ileum: after treatment with corticosteroid, RMCP-II was significantly (P < 0.001) depleted from both immune and naive rats when compared with saline-injected controls (Table 2 ). (iii) Lung: corticosteroids reduced the concentration of RMCP-II in lung homogenates from immune rats ( Table 2 ). The concentrations of RMCP-II in homogenates from naive rats were too low (<10 ,ug per g of tissue) to be measured by radial immunodiffusion, but trace amounts of enzyme were detected in naive animals that had not been treated with corticosteroid (Table 2 ). (iv) Mesenteric lymph node: the concentration of RMCP-II in the nodes of immune rats challenged with antigen was unaltered when compared with that in rats given saline, but corticosteroid depleted the immunized node of RMCP-II ( Table 2) . The values in nodes of untreated naive rats were similar to those in the lung at the limit of detection of the assay system (Table 2) .
Mast Cell Changes After Corticosteroid Treatment. Pretreatment of rats with corticosteroid significantly (P < 0.001, Student's t test) reduced the numbers of MMC in the jejunum and ileum of naive and immune rats. The results were very similar whether the cells were detected by their content of nonspecific esterase (Fig. 1) or with Alcian blue (Table 3 ). The numbers of MMC in the jejunal and ileal mucosae of primed rats were unaltered after challenge with worm antigen (Table 3) . Because of the anisotropic distribution of mast cells in the lung and MLN, a semi-quantitative assessment of cell density was used. Glucocorticoid treatment of sensitized rats caused an apparent reduction in the density of mast cells in both tissues, whereas antigen challenge was without effect (Table 3 ). Relatively few mast cells were present in the lungs of naive rats, and those present in the MLN were distributed in the capsule, with few being located in the cortex. Corticosteroids had no discernible Immunology: King et al. betamethasone (5.6 + 0.2 MMC per VCU) when compared with mast cell numbers in control rats (10.3 ± 0.5 MMC per VCU) treated with saline. The numbers of MMC detected by esterase stain and by Alcian blue were similar, and by regression analysis there was a highly significant correlation between the two staining methods (y = 0.19 + 0.94x; r = 0.93; P < 0.001). Similarly, the concentration of RMCP-II was decreased (P < 0.001) in the jejunum of rats treated with either methylprednisolone (313 + 48 ,ug/g) or betamethasone (493 ± 33 ,g/g) when compared with saline controls (784 + 24 ,ug/g). There was, in addition, a highly significant correlation between the numbers of MMC detected with esterase stain and the concentration of RMCP-II in the jejunum of the three groups of rats (y = 164 + 61x; r = 0.87; P < 0.001).
Dose-Response Relationship. Rats immunized by two previous infections with N. brasiliensis were injected intramuscularly with saline or with 1, 5, or 25 mg of methylprednisolone acetate per kg of body weight 24 and 48 hr before they were killed and bled out. When compared with saline-treated controls, methylprednisolone caused a dose-dependent depletion of RMCP-II within 24 hr from the mucosa ( Table 4 within the granules of a subset of mast cells commonly referred to as "atypical" or "mucosal mast cells" (19) , and the two principal effects of corticosteroid treatment described in the present study were (i) suppression of the anaphylactic release of this enzyme into intestinal secretions and into blood and (ii) depletion of RMCP-II from the intestinal mucosa. These events may, therefore, be related to the suppression of intestinal anaphylaxis and to our failure to detect systemic or enteric release of RMCP-II in primed antigen-challenged rats.
Our results have confirmed previous reports that corticosteroids suppress anaphylactic pathology in the gut (9), there being no detectable permeability changes in the treated immune rats challenged with worm antigen (Table 1) . In addition, they extend earlier observations on the ability of corticosteroids to suppress the development of intestinal mucosal mastocytosis during nematode infection (20, 21) by showing that fully mature MMC in normal and immune rats are depleted by corticosteroid treatment. By contrast, CTMC in the pinna of the ear were apparently unaffected. This latter finding indicates a further important functional difference between CTMC and MMC in the rat.
Significant depletion of MMC and RMCP-II occurred between 4 and 24 hr after exposure to steroid, and this may explain why in previous studies (7) optimal inhibition of anaphylactic bronchoconstriction was not observed until 12-24 hr after dexamethasone administration. The extreme sensitivity of MMC to steroids was indicated by the fact that treatment with as little as 1 mg of methylprednisolone per kg of body weight caused a significant decrease in their numbers (Table 4) .
Depletion of MMC was in every instance paralleled by a loss of RMCP-II from the jejunal mucosa. Both MMC and CTMC were in these studies identified histologically by their content of glycosaminoglycan and of serine esterases. Neither of these granule constituents was depleted from CTMC after steroid treatment, whereas both were lost from MMC. Although depletion of MMC occurred between 4 and 24 hr after treatment, there was no detectable release of RMCP-II into the serum at 1, 4, or 24 hr. The ultimate fate of MMC was not established and must await further study. Corticosteroid treatment of rats passively sensitized intradermally with immune serum caused a highly significant but incomplete inhibition of passive cutaneous anaphylaxis. The binding of IgE to the mast cell surface is not impaired in vitro by steroids (3, 22) and, in the present study, corticosteroids failed to suppress the level of circulating IgE. Consequently, two mechanisms of inhibition of intestinal anaphylaxis might operate: (i) inhibition of mediator release from mast cells by corticosteroids and (ii) modification of the response of target organs to these mast cell-derived mediators. The extent to which the intestinal response was suppressed by the known capacity of steroids to decrease permeability in capillary beds (23) or cause vasoconstriction (24) cannot be determined from the present data. It is possible that both mechanisms operate in the suppression of intestinal permeability changes.
Elevation of cAMP (3, 22) and effects on arachidonic acid metabolism (25) and its inhibition of release from the cell membrane by lipomodulin-like proteins (26) (27) (28) have been put forward to explain corticosteroid inhibition of mediator release from CTMC. However, it is not clear whether these mechanisms are applicable to MMC, as they differ biochemically and functionally (29) from CTMC. But it is interesting to note that one action of corticosteroids may be to impair mitochondrial function (2) , and it is possible that MMC have a greater energy requirement than CTMC.
In summary, pretreatment of sensitized rats with corticosteroids suppresses intestinal anaphylaxis and is associated with a marked depletion of MMC. However, the possibility cannot be ruled out that the depletion of MMC is
